Significant Ownership of Venrock Healthcare Capital Partners III, L.P.

Signature - Title
/s/ Sherman G. Souther - By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Venrock Healthcare Capital Partners III, L.P..

Notify me when Venrock Healthcare Capital Partners III, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Venrock Healthcare Capital Partners III, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORKA ORUKA THERAPEUTICS, INC. Common Stock, par value $0.001 per share 9.9% $94,415,901 +$14,638,312 4,909,619 +18% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
CYBN Cybin Inc. Common Shares, no par value 9.9% $30,106,217 5,111,412 Venrock Healthcare Capital Partners III, L.P. 31 Oct 2025
ENGN enGene Holdings Inc. Common Shares 9.9% $20,185,656 5,046,414 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 9.9% $12,897,307 -$1,376,174 6,353,353 -9.6% Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 9.9% $10,173,886 872,546 Venrock Healthcare Capital Partners III, L.P. 26 Mar 2025
TENX Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.9% $3,317,820 552,970 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
Vor Biopharma Inc. Common Stock, $0.0001 par value per share 9.9% 760,699 Venrock Healthcare Capital Partners III, L.P. 18 Sep 2025
JADE BIOSCIENCES, INC. Common Stock, $0.0001 par value 9.9% 3,220,369 Venrock Healthcare Capital Partners III, L.P. 28 Apr 2025
Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 9.9% 1,391,196 Venrock Healthcare Capital Partners III, L.P. 13 Jun 2025
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 9.4% $49,641,185 +$8,195,110 15,561,500 +20% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
ORIC ORIC Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 7.7% $35,029,459 +$18,130,241 6,596,885 +107% Venrock Healthcare Capital Partners III, L.P. 08 Apr 2025
OCUL Ocular Therapeutix Inc Common Stock, $0.0001 par value per share 7.3% $150,957,880 12,913,420 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
SVRA Savara Inc. Common Stock, par value $0.001 per share 7.3% $45,271,324 +$13,064,544 12,681,043 +41% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
ELVN ENLIVEN THERAPEUTICS, INC. Common Stock, $0.001 par value per share 5.4% $66,042,996 3,226,331 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 4.9% $29,071,814 -$4,971,910 1,016,497 -15% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.7% $1,899,449 3,957,186 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.6% $32,816,175 2,685,448 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share 4.5% $42,152,893 3,575,309 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
ATXS Astria Therapeutics, Inc. Common Stock, $0.001 par value per share 4.4% $10,025,980 2,457,348 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
APLT Applied Therapeutics, Inc. Common Stock $0.0001 par value per share 4.1% $1,781,667 -$1,996,029 5,567,709 -53% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
PHVS Pharvaris N.V. Ordinary shares, par value EURO0.12 per share 3.8% $46,767,641 2,047,620 Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
CDTX CIDARA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 3.2% $42,793,332 -$30,795,440 639,088 -42% Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
DNTH Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share 3.1% $24,810,000 1,000,000 Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
AQST Aquestive Therapeutics, Inc. Common stock, $0.001 par value per share 2.9% $6,232,593 2,629,786 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
MRSN MERSANA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 2.9% $1,072,298 -$2,005,040 3,574,325 -65% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 1.5% $1,795,640 -$6,028,143 677,600 -77% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
ABVX Abivax SA Ordinary Shares, nominal value 0.01 euro per share 0.8% $48,964,292 576,729 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
ADVM ADVERUM BIOTECHNOLOGIES, INC. Common Stock, $0.0001 par value 0% $0 0 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024

Schedules 13D/G Reported by Venrock Healthcare Capital Partners III, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.